S. N. Thibodeau

1.4k total citations
17 papers, 508 citations indexed

About

S. N. Thibodeau is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. N. Thibodeau has authored 17 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. N. Thibodeau's work include Genetic factors in colorectal cancer (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastric Cancer Management and Outcomes (3 papers). S. N. Thibodeau is often cited by papers focused on Genetic factors in colorectal cancer (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Gastric Cancer Management and Outcomes (3 papers). S. N. Thibodeau collaborates with scholars based in United States, Australia and Canada. S. N. Thibodeau's co-authors include Steve Gallinger, Daniel J. Sargent, Noralane M. Lindor, Loı̈c Le Marchand, Polly A. Newcomb, Michelle Cotterchio, John A. Baron, Robert W. Haile, Allyson Templeton and Jeremy R. Jass and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Chemistry and Analytica Chimica Acta.

In The Last Decade

S. N. Thibodeau

17 papers receiving 495 citations

Peers

Countries citing papers authored by S. N. Thibodeau

Since Specialization

Citations

This map shows the geographic impact of S. N. Thibodeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. N. Thibodeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. N. Thibodeau more than expected).

Fields of papers citing papers by S. N. Thibodeau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. N. Thibodeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. N. Thibodeau. The network helps show where S. N. Thibodeau may publish in the future.

Co-authorship network of co-authors of S. N. Thibodeau

This figure shows the co-authorship network connecting the top 25 collaborators of S. N. Thibodeau. A scholar is included among the top collaborators of S. N. Thibodeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. N. Thibodeau. S. N. Thibodeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	1054 Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH 2015 ·European Journal of Cancer ·Aung Ko Win, (unknown), James G. Dowty, Daniel D. Buchanan, Mark Clendenning, Juan I. Young, Sean P. Cleary, Michelle Cotterchio, (unknown), Jeffrey Baron, Loı̈c Le Marchand, G. Casey, R. W. Haile, Polly A. Newcomb, S. N. Thibodeau, JL Hopper, Steve Gallinger, Ingrid Winship, Noralane M. Lindor, Mark A. Jenkins	9
2	Influence of KRAS and BRAF mutational status and rash on disease-free survival (DFS) in patients with resected stage III colon cancer receiving cetuximab (Cmab): Results from NCCTG N0147. 2011 ·Journal of Clinical Oncology ·Steven R. Alberts, S. N. Thibodeau, Daniel J. Sargent, M. R. Mahoney, Frank A. Sinicrope, A. F. Shields, Elcie Chan, Richard M. Goldberg, Sharon A. Gill, Morton S. Kahlenberg, (unknown), T. C. Smyrk, Axel Grothey, (unknown)	2
3	Adjuvant FOLFIRI with or without cetuximab in patients with resected stage III colon cancer: NCCTG Intergroup phase III trial N0147. 2011 ·Journal of Clinical Oncology ·Jin Huang, Daniel J. Sargent, M. R. Mahoney, S. N. Thibodeau, T. C. Smyrk, Frank A. Sinicrope, (unknown), Steven R. Alberts	9
4	Colorectal cancer cases with de novo germ-line mutations in MLH1, MSH2, and MSH6 from the Colon Cancer Family Registry. 2011 ·Journal of Clinical Oncology ·Aung Ko Win, Mark A. Jenkins, Daniel D. Buchanan, Joanne Young, S. N. Thibodeau, John L. Hopper, Noralane M. Lindor	1
5	Adjuvant mFOLFOX6 plus or minus cetuximab (Cmab) in patients (pts) with KRAS mutant (m) resected stage III colon cancer (CC): NCCTG Intergroup Phase III Trial N0147. 2010 ·Journal of Clinical Oncology ·Richard M. Goldberg, Daniel J. Sargent, S. N. Thibodeau, M. R. Mahoney, A. F. Shields, Elcie Chan, Sanjeev Gill, Morton S. Kahlenberg, S. Asha Nair, Steven R. Alberts	36
6	Adjuvant mFOLFOX6 with or without cetuxiumab (Cmab) in KRAS wild-type (WT) patients (pts) with resected stage III colon cancer (CC): Results from NCCTG Intergroup Phase III Trial N0147. 2010 ·Journal of Clinical Oncology ·Steven R. Alberts, Daniel J. Sargent, T. C. Smyrk, A. F. Shields, Elcie Chan, Richard M. Goldberg, Sarah Gill, Morton S. Kahlenberg, S. N. Thibodeau, (unknown)	63
7	Lynch syndrome TACSTD1 family with predominant colorectal cancer. 2010 ·Journal of Clinical Oncology ·Henry T. Lynch, S. N. Thibodeau, (unknown), J. F. Lynch, (unknown), C. Richard Boland, P. M. Lynch, Douglas L. Riegert‐Johnson	1
8	Interlaboratory assay reproducibility study for loss of heterozygosity on chromosome 18 (18q LOH) in colon cancer 2009 ·Journal of Clinical Oncology ·J. M. Jessup, Kevin K. Dobbin, Stephanie Hamilton, S. N. Thibodeau, Mark Redston, Sheila E. Taube, (unknown), Jacqueline Benedetti	1
9	Confirmation of deficient mismatch repair (dMMR) as a predictive marker for lack of benefit from 5-FU based chemotherapy in stage II and III colon cancer (CC): A pooled molecular reanalysis of randomized chemotherapy trials 2008 ·Journal of Clinical Oncology ·Daniel J. Sargent, Silvia Marsoni, S. N. Thibodeau, Roberto Labianca, Stanley R. Hamilton, Valter Torri, G. Monges, Christine Ribic, Axel Grothey, Steve Gallinger	60
10	Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer 2007 ·Cancer Epidemiology Biomarkers & Prevention ·Polly A. Newcomb, John A. Baron, Michelle Cotterchio, Steve Gallinger, John Grove, Robert W. Haile, David Hall, John L. Hopper, Jeremy R. Jass, Loı̈c Le Marchand, Paul J. Limburg, Noralane M. Lindor, John D. Potter, Allyson Templeton, S. N. Thibodeau, Daniela Seminara, (unknown)	222
11	Developments toward a complete micro-total analysis system for Duchenne muscular dystrophy diagnosis 2003 ·Analytica Chimica Acta ·Jerome P. Ferrance, (unknown), Braden C. Giordano, (unknown), Yien Chian Kwok, Karen Snow, S. N. Thibodeau, James P. Landers	58
12	Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling (vol 26, pg 146, 2000) 2000 ·Data Archiving and Networked Services (DANS) ·(unknown), X. Dong, (unknown), Ratnam S. Seelan, Kazuhiro Taniguchi, Kausilia K. Krishnadath, Kevin C. Halling, John M. Cunningham, Lisa A. Boardman, Qian Chen, Erik Christensen, Sabine Schmidt, Patrick C. Roche, Daniel Smith, S. N. Thibodeau	3
13	Molecular abnormalities in colorectal cancer: Microsatellite instability pathway 1998 ·Julie M. Cunningham, Lisa A. Boardman, Lawrence J. Burgart, S. N. Thibodeau	2
14	Rektumkarzinome bei HNPCC 1998 ·PubMed ·(unknown), (unknown), S. N. Thibodeau, Roger R. Dozois	15
15	Mutator gene effect in colorectal cancer 1994 ·Clinical Chemistry ·S. N. Thibodeau	1
16	Eight novel polymorphisms in the dystrophin gene of african-americans: The rate of polymorphism is high 1993 ·Human Mutation ·Noralane M. Lindor, Steve S. Sommer, Janet L. Sobell, Leonard L. Heston, S. N. Thibodeau	2
17	The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemia. 1990 ·PubMed ·Ayalew Tefferi, Gary D. Bren, (unknown), Dan Schaid, Robert C. Ash, S. N. Thibodeau	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact